3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain
4
Pain, Postoperative
3
Agnosia
3
Ovarian Neoplasms
2
Inflammation
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Thyroid Nodule
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Obesity
1
Neoplasms
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Liver Diseases
1
Kidney Neoplasms
1
Ileus
1
Goiter
1
Emergencies
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Curative Breast Cancer Surgery
1
Constipation
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chronic Pain
1
Interventions
Ketamine
4
Oxycodone
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Transcutaneous Electric Nerve Stimulation
1
Tea
1
Surveys and Questionnaires
1
Ropivacaine
1
Psychotherapy
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ibuprofen
1
Hydromorphone
1
Fentanyl
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Control Groups
1
Circumcision, Male
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Acute Pain
×
Ketorolac
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled